Weight Loss Management in Endometrial Cancer Survivors (ECS Weight)
Status
Conditions
Treatments
Details and patient eligibility
About
This study is being done to understand how oncologists can engage a multidisciplinary team to help endometrial cancer survivors with obesity to engage in a weight management program and potentially start a weight loss medication. Obesity often impacts the future health and longevity of early-stage endometrial cancer survivors more than their cancer diagnosis.
Patients will be referred to the KUMC OB/Gyn weight management clinic to discuss weight management options.
- If patients decide to use medications for weight loss, then the study will collect data from their chart that is recorded as part of routine monitoring for patients on weight loss medications.
- If patients decide not to use any medications, the study will monitor physical exam and lab data collected as part of their routine medical care.
The study will also try to understand reasons why patients did or did not start using a weight loss medication.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- ≥18 years old
- ECOG 0-2
- BMI ≥ 30kg/m2
- Completed surgical staging with no evidence of residual disease
- Endometrioid endometrial adenocarcinoma, p53 wild type
- Stage 1
- Undergoing active surveillance +/- brachytherapy
Exclusion criteria
- Unable to participate in behavior weight loss
- Stroke, heart attack, end stage liver disease, or end stage kidney disease during the last 6 months.
- Currently on a GLP-1 agonist
- Currently on insulin
Trial design
50 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Co-investigator; Principal Investigator
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal